CATALOGO DEI PRODOTTI DELLA RICERCA

LATTUADA, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.203
EU - Europa 1.782
AS - Asia 1.295
SA - Sud America 223
Continente sconosciuto - Info sul continente non disponibili 75
AF - Africa 40
OC - Oceania 2
Totale 5.620
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.115
RU - Federazione Russa 728
SG - Singapore 524
CN - Cina 380
GB - Regno Unito 306
BR - Brasile 184
IT - Italia 152
VN - Vietnam 123
SE - Svezia 115
DE - Germania 105
IE - Irlanda 96
FR - Francia 88
HK - Hong Kong 87
FI - Finlandia 74
CA - Canada 42
KR - Corea 39
BD - Bangladesh 28
UA - Ucraina 28
JP - Giappone 22
IN - India 20
MX - Messico 18
AR - Argentina 17
CZ - Repubblica Ceca 17
ZA - Sudafrica 16
TR - Turchia 14
NL - Olanda 13
PL - Polonia 13
BE - Belgio 10
NG - Nigeria 10
ES - Italia 8
AT - Austria 7
ID - Indonesia 7
CW - ???statistics.table.value.countryCode.CW??? 6
IQ - Iraq 6
SA - Arabia Saudita 6
CL - Cile 5
IL - Israele 5
LT - Lituania 5
PH - Filippine 5
PK - Pakistan 5
SV - El Salvador 5
UZ - Uzbekistan 5
CO - Colombia 4
CR - Costa Rica 4
EG - Egitto 4
NI - Nicaragua 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
GR - Grecia 3
GT - Guatemala 3
MA - Marocco 3
PY - Paraguay 3
RO - Romania 3
VE - Venezuela 3
AM - Armenia 2
AU - Australia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CD - Congo 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GP - Guadalupe 1
GY - Guiana 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
MN - Mongolia 1
QA - Qatar 1
SC - Seychelles 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.553
Salva come PNG Salva come JPEG
Città #
Singapore 292
Moscow 253
Southend 246
Chandler 235
Ashburn 209
San Jose 209
Jacksonville 153
Woodbridge 127
Dublin 95
Dallas 93
Hong Kong 87
Council Bluffs 80
Beijing 75
Ann Arbor 70
New York 51
Los Angeles 46
Verona 45
The Dalles 42
Houston 41
Ho Chi Minh City 38
Lawrence 33
Princeton 33
Jinan 32
Wilmington 29
Munich 28
Shenyang 27
Helsinki 26
Santa Clara 25
Hanoi 24
Nanjing 23
São Paulo 21
Tokyo 20
Buffalo 17
Montreal 17
Denver 16
Brno 15
Hebei 15
Orem 15
Frankfurt am Main 13
Redondo Beach 13
Toronto 13
Turku 13
Warsaw 13
Atlanta 12
Phoenix 12
London 11
Nanchang 11
Ningbo 11
Bologna 10
Brussels 10
Milan 10
San Francisco 10
Seoul 10
Tianjin 10
Abuja 9
Boardman 9
Changsha 9
Johannesburg 9
Amsterdam 8
Chicago 8
Haikou 8
Hangzhou 8
Redmond 8
Rio de Janeiro 8
Sindelfingen 8
Zhengzhou 8
Boston 7
Brooklyn 7
Chennai 7
Jiaxing 7
Lanzhou 7
Clearwater 6
Guangzhou 6
Haiphong 6
Mexico City 6
Norwalk 6
Seattle 6
Stockholm 6
Taizhou 6
Turin 6
Willemstad 6
Dong Ket 5
Pignone 5
Providence 5
Rome 5
Belo Horizonte 4
Bursa 4
City of London 4
Madrid 4
Managua 4
Manchester 4
Monterrey 4
Mumbai 4
Paris 4
Poplar 4
Querétaro 4
San Salvador 4
Scandiano 4
Taiyuan 4
Tashkent 4
Totale 3.360
Salva come PNG Salva come JPEG
Nome #
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report. 208
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection. 199
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 196
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 194
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 193
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era. 187
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 186
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 183
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 182
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 182
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 180
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 178
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 178
No improvement of lipodystrophy syndrome in an HIV-infected patient. 175
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 174
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 173
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? 170
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 168
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 168
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 164
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 163
Efficacy and safety of TAM-sparing antiretroviral regimens in naive HIV-positive patients 154
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 153
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 151
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 149
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up 142
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 139
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 137
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 130
Raltegravir: is a 400 mg once-daily dose enough? 130
mIRTAZAPINE IN AN HIV-INFECTED PATIENT WITH PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 129
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 114
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 112
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 92
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 46
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 41
Totale 5.620
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.629
article - articoli 19.177
book - libri 0
conference - conferenze 452
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.258
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022166 0 0 0 25 2 3 3 19 15 11 16 72
2022/2023620 36 85 50 94 62 154 0 39 77 2 10 11
2023/2024287 16 26 30 21 36 48 2 17 3 14 40 34
2024/2025673 37 41 15 97 38 13 37 18 112 46 62 157
2025/20262.361 146 112 119 425 657 161 177 88 215 157 45 59
2026/2027329 22 53 57 197 0 0 0 0 0 0 0 0
Totale 5.620